NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Summer’s sweltering heat makes autumn seem far away, but at CSL Seqirus in Holly Springs, N.C., it signals shipping time for the company’s portfolio of 2024-2025 seasonal influenza vaccines. On July 9, the company began shipping its vaccines to healthcare providers across the U.S. before fall’s annual flu vaccination campaigns. 

The Holly Springs site has been hard at work manufacturing influenza vaccines for this season since the World Health Organization announced the recommended influenza vaccine composition for the northern hemisphere on Feb. 23.

Nipro Medical Corp., a medical equipment company based in Osaka, Japan, plans to invest $397.8 million to develop a new manufacturing facility and create more than 232 jobs in Greenville, N.C., one of Pitt County’s growing cities.

The state and the company announced the news at an event in Greenville on Wednesday, after the N.C. Department of Commerce's Economic Investment Committee (EIC) approved incentives for the project. Pitt County officials passed incentives last month.

A Morrisville-based biopharmaceutical company has received special regulatory status for a potential new treatment for acute pancreatitis.

Cambrex, a global contract development and manufacturing organization (CDMO) with operations in High Point and Durham, has announced that its stability storage business known as Q1 Scientific will open a new state-of-the-art facility in Durham later this year. Q1 offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries. 

A Swedish cancer diagnostics developer is reinventing itself and transplanting its North American headquarters from the Boston area to North Carolina’s booming Research Triangle area to become more efficient and effective.

A California medical technology startup plans to expand the Research Triangle Park facility it bought in 2022, adding 50 jobs and spending up to $65 million on the project.

Science Corp. in Alameda, Calif., is developing brain-computer interface devices such as a visual prosthesis for degenerative retinal diseases. The devices will be manufactured by the company’s Science Foundry division, using its MEMS (microelectromechanical systems) foundry at Alexander Drive and Cornwallis Road.

Verona Pharma announced it has received FDA approval for Ohtuvayre (Ensifentrine), a maintenance treatment for chronic obstructive pulmonary disease (COPD) in adult patients. It is the first inhaled product available for the disease and is delivered directly to the lungs through a standard jet nebulizer.

Science, innovation and entrepreneurship are the key ingredients in bringing forward new medical therapies and treatment options for patients. But these will never successfully come together at the right time and in the right quantities if they are not mixed in an environment where they can flourish.

For 40 years, the North Carolina Biotechnology Center has been that environment. The discoveries by our life sciences companies, universities, medical centers and research organizations would be less available to meet human needs if not for the vital role NCBiotech plays.

TruLab, a provider of technology for overseeing drug clinical trials, has relocated to new offices in Research Triangle Park (RTP) to support its rapid growth and development.

The company has signed a two-year lease for 10,000 square feet of space in Frontier RTP, the research park’s coworking and office campus.

Claradele Pharmaceuticals, a Greenville startup developing a unique immunotherapy for metastatic melanoma, is the 2024 NCBiotech Venture Challenge winner. 

The Claradele selection marked the pinnacle of a months-long grooming process for North Carolina’s freshest life sciences startups. It was the culmination of the statewide Venture Pitch Showcase at the Grandover Resort in Greensboro, announced Thursday evening at the sold-out Triad BioNight, also at the Grandover.

Five of the Piedmont Triad region’s most impactful individuals and organizations in the life sciences have been honored with Excellence Awards.

The awards were given at Triad BioNight, a celebration of the region’s life sciences industry organized by the Piedmont Triad Office of the North Carolina Biotechnology Center. About 400 people attended the networking and awards event June 27 at the Grandover Resort and Spa in Greensboro.

Millions of consumers know Bayer as the aspirin company. Some even know it’s the Alka-Seltzer company. Investors know it as the German pharmaceutical, life sciences and agricultural giant that bought Monsanto in 2018.

Now Bayer is buying a bigger bite of plant technology developed by Pairwise, a North Carolina gene-based ag tech company, to expand its reach into the grocery food chain.

As NCBiotech’s Vice President of Talent and Culture Development, I have the privilege of observing and shaping our organization’s culture. On our 40th anniversary, I’ve been reflecting on the critical role that our staff, culture and collaboration play in growing North Carolina’s life sciences.  

In the largest capital investment ever in North Carolina’s life sciences, Novo Nordisk plans to invest $4.1 billion to expand its fill and finish operations in Johnston County, creating 1,000 new jobs and adding 1.4 million square feet of new manufacturing space.

The new facility will expand the Danish company’s current operations in Clayton and will grow the company’s ability to produce injectable treatments for people with diabetes, obesity and other chronic diseases. 

North Carolina-based Advanced Medicine Partners has announced a new financing agreement led by Deerfield Management, with additional support from ARCH Venture Partners and other investors. Once complete, this latest funding round of $32 million will bring the total direct investment in Advanced Medicine Partners to $60 million since its separation from Jaguar Gene Therapy.

scroll back to top of page